Frances Taylor Goldman, | |
7600 York Rd, Towson, MD 21204-7500 | |
(410) 740-8066 | |
Not Available |
Full Name | Frances Taylor Goldman |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 7600 York Rd, Towson, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750926507 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 21874 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Frances Taylor Goldman, 10630 Little Patuxent Pkwy Ste 209, Columbia, MD 21044-6278 Ph: () - | Frances Taylor Goldman, 7600 York Rd, Towson, MD 21204-7500 Ph: (410) 740-8066 |
News Archive
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.
A new study has shown that COVID-19 patients admitted to the Intensive care unit may be resistant to the naturally occurring anticoagulant Heparin. The study titled, "Heparin resistance in COVID‑19 patients in the intensive care unit," was published in the latest issue of the Journal of Thrombosis and Thrombolysis.
BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).
› Verified 1 days ago
Mrs. Hilary Schneider Fink, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 200 E Joppa Rd Ste 400, Towson, MD 21286 Phone: 410-828-0101 Fax: 410-828-6262 | |
Mrs. Susan Kathleen Power, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 120 Sister Pierre Dr, Suite 407, Towson, MD 21204 Phone: 443-279-2000 Fax: 443-279-2004 | |
Ms. Alexandra Elizabeth Freas, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6901 N Charles St, Towson, MD 21204 Phone: 443-845-9559 | |
Mrs. Ashley Senger, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6901 N Charles St, Towson, MD 21204 Phone: 443-809-4130 | |
Jennifer Lynn Hollern, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6901 N Charles St, Towson, MD 21204 Phone: 443-809-4554 | |
Barry Roysdon, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 605 Baltimore Ave, Towson, MD 21204 Phone: 410-428-2458 | |
Gina Marie Rossetti, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 602 Providence Rd, Towson, MD 21286 Phone: 240-405-7212 |